These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6598227)

  • 1. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C; Cruz A; Codoceo V
    Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
    Petitclerc C; Barry A
    Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396
    [No Abstract]   [Full Text] [Related]  

  • 3. [Varying course of pancytopenia after busulfan treatment of chronic myelocytic leukemia (CML)].
    Krug K; Stenzel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):181-7. PubMed ID: 79522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors in chronic myeloid leukemia. Apropos of 798 cases].
    Jacquillat C; Chastang C; Bancalari G; Weil M; Bernard J
    Ann Med Interne (Paris); 1975; 126(6-7):515-20. PubMed ID: 1065252
    [No Abstract]   [Full Text] [Related]  

  • 5. A retrospective study of patients with chronic myeloid leukemia diagnosed and treated at the Chaim Sheba Medical Center during the years 1966-76.
    Inbal A; Modan M; Many A
    Isr J Med Sci; 1978 Dec; 14(12):1259-64. PubMed ID: 285048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aplasia caused by busulfan in chronic myeloid leukemia].
    Perol C; Najean Y; Tanzer J; Jacquillat C; Boiron M; Bernard J
    Nouv Rev Fr Hematol; 1967; 7(6):884-9. PubMed ID: 4230381
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of chronic granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1977 Dec; 137(12):1717-8. PubMed ID: 270965
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pathologic conference: Chronic myelogenous leukemia with fever and progressive pulmonary insufficiency of undetermined origin.
    South Med J; 1975 Apr; 68(4):511-9. PubMed ID: 1054889
    [No Abstract]   [Full Text] [Related]  

  • 9. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E
    Minerva Med; 1970 May; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR; Hurley TH; Bolton JH
    Cancer Treat Rep; 1977; 61(1):43-5. PubMed ID: 266418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the prognosis of chronic myeloid leukemia through current treatment].
    Donner L; Klener P; Roth Z
    Vnitr Lek; 1976 Feb; 22(2):114-9. PubMed ID: 1062868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical conference: Thrombocythemic introduction to chronic myeloid leukemia].
    Bauters F; Goudemand M
    Nouv Rev Fr Hematol; 1975; 15(2):241-4. PubMed ID: 126433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary fibrosis after busulfan therapy].
    Jandl H; Franke A; Albrecht G
    Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical and laboratory prognostic indices in chronic myeloid leukemia (author's transl)].
    Kotlarek-Haus S; Becker M; Dorczak K
    Przegl Lek; 1977; 34(4):407-11. PubMed ID: 267958
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic myelosis].
    Meister H
    Z Gesamte Inn Med; 1976 Apr; 31(7):203-7. PubMed ID: 1067696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis of atypical chronic myeloid leukaemia].
    Klein UE; Schwarze EW; Schwalbe P; Tolksdorf ME
    Dtsch Med Wochenschr; 1976 Jun; 101(24):915-20. PubMed ID: 1064523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Busulfan and eye complications].
    Tuppurainen K; Nousiainen T; Lahtinen R
    Duodecim; 1985; 101(24):2420-2. PubMed ID: 3866686
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic myeloid leukaemia: course, life expectancy, and an analysis of dibromomannitol and busulfan treatment.
    Gerhartz H
    Haematologica; 1972 Apr; 57(11):775-86. PubMed ID: 4200312
    [No Abstract]   [Full Text] [Related]  

  • 19. [Survival in chronic myeloid leukemia following aplasia caused by Misulban].
    Perreau P; Gardais J
    Sem Hop; 1969 Mar; 45(15):964-70. PubMed ID: 4307171
    [No Abstract]   [Full Text] [Related]  

  • 20. [Degenerative retinal conditions after treatment with Busulfan during pregnancy (author's transl)].
    Saraux H; Lefrancois A
    Klin Monbl Augenheilkd; 1977 Jun; 170(6):818-20. PubMed ID: 268448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.